These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21513911)

  • 1. Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
    Fast S; Bonnema SJ; Hegedüs L
    Ann Endocrinol (Paris); 2011 Apr; 72(2):129-35. PubMed ID: 21513911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
    Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
    Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of radioiodine therapy in benign nodular goitre.
    Bonnema SJ; Fast S; Hegedüs L
    Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):619-31. PubMed ID: 25047210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.
    Ceccarelli C; Brozzi F; Bianchi F; Santini P
    Minerva Endocrinol; 2010 Sep; 35(3):161-71. PubMed ID: 20938419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
    Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human thyrotropin stimulation prior to
    Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
    Jedrzejuk D; Milewicz A
    Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH.
    Cardia MS; Rubio IG; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):474. PubMed ID: 16584523
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin?
    Huysmans DA; Nieuwlaat WA; Hermus AR
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):297-9. PubMed ID: 15008993
    [No Abstract]   [Full Text] [Related]  

  • 14. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
    Medeiros-Neto G; Marui S; Knobel M
    Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.
    Kaniuka S; Lass P; Sworczak K
    Nucl Med Rev Cent East Eur; 2009; 12(1):23-9. PubMed ID: 19554518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy of euthyroid multinodular goitres.
    Manders JM; Corstens FH
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S466-70. PubMed ID: 12192547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
    Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
    Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.